Detalles de la búsqueda
1.
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning.
J Clin Psychopharmacol
; 41(4): 414-420, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181362
2.
Use of the single-item Patient Global Impression-Severity scale as a self-reported assessment of insomnia severity.
J Sleep Res
; 30(1): e13141, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210445
3.
Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease.
J Sleep Res
; 30(6): e13328, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34340251
4.
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Brain
; 143(12): 3816-3826, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253354
5.
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.
Alzheimers Dement
; 16(3): 541-551, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31944580
6.
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
Alzheimers Dement
; 16(11): 1483-1492, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33049114
7.
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
Int J Neuropsychopharmacol
; 20(8): 613-618, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28582570
8.
EEG spectral analysis of NREM sleep in a large sample of patients with insomnia and good sleepers: effects of age, sex and part of the night.
J Sleep Res
; 26(1): 92-104, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634437
9.
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.
Am J Geriatr Psychiatry
; 25(7): 791-802, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28427826
10.
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine.
Cephalalgia
; 36(2): 148-61, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926620
11.
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis.
Cephalalgia
; 35(5): 379-88, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25106663
12.
Addition of an NK1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder.
Hum Psychopharmacol
; 29(6): 568-77, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25330122
13.
Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorder.
Int J Neuropsychopharmacol
; 16(1): 1-11, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22433185
14.
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
Headache
; 53(1): 104-117, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23078588
15.
Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia.
Hum Psychopharmacol
; 28(2): 124-33, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23532746
16.
Comparison of polysomnography in people with Alzheimer's disease and insomnia versus non-demented elderly people with insomnia.
Sleep Med
; 101: 515-521, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529106
17.
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
J Alzheimers Dis
; 92(1): 341-348, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36744336
18.
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
Cephalalgia
; 32(10): 750-65, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22711898
19.
Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
Headache
; 52(2): 224-35, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22221076
20.
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Cephalalgia
; 31(3): 296-300, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20937606